PAG
PFE icon

Private Advisor Group’s Pfizer PFE Stock Holding History

Private Advisor Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-7,000
Closed -$18.2K – 2396
2023
Q4 		$18.2K Sell
7,000
-75,300
-91% -$2.28M ﹤0.01% 2197
2023
Q3 		$27.3K Buy
+82,300
New +$2.91M ﹤0.01% 2082

Other funds holding PFE

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
SLAM
Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Private Advisor Group's PFE Position: Q2 2026 in Review

Private Advisor Group reduced its Pfizer (PFE) stake by 5.7% in Q2 2026, selling an estimated $1.18M and leaving 744,034 shares worth $17.9M. The position accounts for 0.08% of the portfolio, ranked #256.

Private Advisor Group first reported a position in PFE in Q4 2013 and has held it in 51 quarters since. The position peaked at $46.4M in Q4 2021. 1,179 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Private Advisor Group held 744,034 shares of Pfizer worth $17.9M as of Q2 2026.
  • Private Advisor Group sold 45,018 Pfizer shares in Q2 2026, an estimated $1.18M.
  • Pfizer made up 0.08% of Private Advisor Group's portfolio in Q2 2026, its #256 holding.
  • Private Advisor Group first reported a position in Pfizer in Q4 2013 and has held it in 51 quarters since.
  • Private Advisor Group's Pfizer position peaked at $46.4M in Q4 2021.
  • 1,179 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.